Genmab A (GMAB) Net Margin: 2018-2021
- Genmab A's Net Margin fell 3969.00% to 0.00% in Q2 2021 from the same period last year, while for Jun 2021 it was 0.00%, marking a year-over-year decrease of 1252.00%. This contributed to the annual value of 47.06% for FY2020, which is 669.00% up from last year.
- Per Genmab A's latest filing, its Net Margin stood at 0.00% for Q2 2021, which was down 100.00% from 38.92% recorded in Q4 2020.
- Genmab A's Net Margin's 5-year high stood at 67.21% during Q4 2019, with a 5-year trough of -26.63% in Q2 2019.
- Its 3-year average for Net Margin is 23.84%, with a median of 38.92% in 2020.
- Per our database at Business Quant, Genmab A's Net Margin soared by 6,631bps in 2020 and then crashed by 3,969bps in 2021.
- Quarterly analysis of 4 years shows Genmab A's Net Margin stood at 38.52% in 2018, then skyrocketed by 2,869bps to 67.21% in 2019, then plummeted by 2,829bps to 38.92% in 2020, then crashed by 3,969bps to 0.00% in 2021.
- Its last three reported values are 0.00% in Q2 2021, 38.92% for Q4 2020, and 39.69% during Q2 2020.
